Saturday, October 31, 2026

IMF Predicts China's Economy to Rebound With a Bang: 4%+ Growth Expected in Q2

IMF Deputy Managing Director Gita Gopinath predicted at the World Economic Forum that China could see 4% growth in Q2 following the removal of health restrictions.

LM Salvado
LM Salvado

January 19, 2023

The International Monetary Fund (IMF)

According to Gita Gopinath, the Deputy Managing Director of the International Monetary Fund (IMF), China could see a sharp recovery in economic growth from the second quarter onwards based on current infection trends after the dismantling of most health restrictions.

Speaking on the sidelines of the World Economic Forum in Davos, Gopinath stated that "They moved away dramatically away from their zero code policy we are seeing infections rise that's going to have an effect on economic activity in the first couple of months of this year." However, she also noted that "at least looking at the trends inflation Trends and if sorry the infection Trends and if those persist we could see a very quick recovery starting from you know after the first quarter of the theory maybe even sooner in some places."

Gopinath went on to say that "we expect growth in China to come back to rebound if growth in China comes in in the like the four percent Plus ballpark then I think you know given that Global demand is slowing even if China comes back up that you know those would be balancing factors." She also acknowledged the possibility of a stronger than expected recovery in China, stating that "if say growth in China comes in much more strongly which is a possibility uh then we could see another spike in uh oil prices for instance or in Energy prices."

Overall, Gopinath's comments indicate that the IMF is optimistic about China's economic recovery in the coming months, but also notes that the country's recent rise in infections may have an impact on economic activity in the short term.

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com